Request to Join
has invited you to join this group
A/Prof. Jeremy Cohen qualified from Charing Cross and Westminster Medical School in 1990, where he also obtained a BSc in Biochemistry. He undertook a post graduate career in clinical medicine and anaesthesia before moving to Australia to pursue a career in Intensive Care Medicine. He is currently a Senior Staff Specialist at the Royal Brisbane and Women’s Hospital in Queensland, the Deputy Director of the Intensive Care Unit of Wesley Hospital and an Associate Professor in the University of Queensland.
Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and. at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia.
He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine. He then undertook a research degree from the University of Birminghan, UK which led to the award of an MD. He pioneered the development of a continuous blood gas monitoring system which reached clinical application.
He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014-2016. He is the Principal Investigator of the NHMRC funded multi-center international ADRENAL trial which is largest septic shock trial to date. This was published in the New England Journal of Medicine. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state, sepsis and vitamin D in critical illness. He has published more than 180 papers, and 40 book chapters.
He is the organizer of the Brisbane Examination course for the Fellowship in ICU which he set up in 1998. He has also run courses on Data Interpretation in Acute Medicine for the last 12 years in Australia and internationally.
Prof John Myburgh AO is Professor of Intensive Care Medicine at the University of New South Wales and Director of the Division of Critical Care at the George Institute for Global Health, Sydney, Australia. He is senior Intensive Care Physician at St George Hospital, Sydney
He is Past-Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group and led over 35 clinical trials in Intensive Care Medicine, including the SAFE, NICE-SUGAR, RENAL and CHEST trials. He was a Lead Investigator on the ADRENAL trial.
His current h-index is 39, calculated from 176 publications in SCOPUS, yielding over 11000 citations, with a citation trajectory of 800 to 1400 citations per annum from 2010 to the present.
He has made a substantive contribution to education in Intensive Care Medicine, and was instrumental in establishing the College of Intensive Care Medicine, serving as a Fellowship examiner for twelve years, on the Board for ten years and as the elected President from 2010-2012.
He is the current Secretary-General of the World Federation of Societies of Intensive and Critical Care Medicine.
Dr. Bellissant is Head of the Department of Clinical and Biological Pharmacology and of the Pharmacovigilance, Pharmaco-epidemiology and Drug Information Centre of the University of Rennes School of Medicine and of Rennes University Hospital. He holds the rank of Outstanding Class Professor; He created and directed the Rennes INSERM Clinical Investigation Centre between 2002 and 2016. He also created, in 2006, and still directs a master’s training entitled “Modeling in Clinical Pharmacology and Epidemiology”. Dr. Bellissant’ research interests include translational, clinical pharmacology, randomized clinical trials, pharmaco-epidemiology, and prognosis factors research studies on sepsis and congestive heart failure and pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD modeling of new drugs in cardiovascular and infectious fields. Dr. Bellissant has designed and analyzed and/or conducted several large French Health Ministry-funded multicenter studies, notably in the critically ill, published about 140 papers among which 100 were signed as 1st, 2nd or last author.
Karim Asehnoune got his degree as MD in 1999 at University René Descartes Paris, France. After completing his PhD in immunology in 2001, he spent one year in the lab of Pr Edward Abraham in the University of Colorado, Denver, USA (2002). He was appointed Professor of Anaesthesiology and Critical Care Medicine in the University of Nantes (France) in 2009. Professor Asehnoune is the head of the Anaesthesiology department of Hospital Hotel-Dieu, and the director of the 30-bed surgical Intensive Care Unit at the University hospital of Nantes, France. He is currently member of the scientific committee of the French Society of Anaesthesiology and Critical Care Medicine, and the director of a French network of ICUs (www.ATLANREA.org). Professor Asehnoune was involved as the coordinator of several multi-centre trials, and he was the primary investigator of 2 multicentre double blind randomised studies evaluating corticosteroids in severe trauma patients. He is the director of a lab dedicated to the study of host-pathogen interactions (http://www.ea3826.univ-nantes.fr/). He has published more than 170 peer-reviewed articles.
Djillali Annane is Dean of the School of Medicine Simone Veil at University of Versailles- Paris Saclay, Director of the general intensive care department at Raymond Poincaré hospital, Assistance Publique Hôpitaux de Paris; (APHP), and Chief Counsellor of the French Minister of Health for medical education and research.